CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 32.29
  • -0.21-0.65%
Noon Break Dec 3 11:29 CST
24.87BMarket Cap26.66P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese patent medicine3.06B77.25%
Western medicine623.3M15.72%
Other273.14M6.89%
Other business5.37M0.14%
Other----
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Chinese patent medicine3.06B77.25%
Western medicine623.3M15.72%
Other273.14M6.89%
Other business5.37M0.14%
Other----
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
Territory3.94B99.28%
Overseas23.29M0.59%
Other business5.37M0.14%
Other----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data